Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results from the Study of Health in Pomerania (SHIP)
- PMID: 21039324
- DOI: 10.3109/13685538.2010.524955
Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results from the Study of Health in Pomerania (SHIP)
Abstract
Objective: There is increasing evidence suggesting that low total testosterone concentration is associated with incident type 2 diabetes mellitus (T2DM) in men. The aim of this study was to evaluate the association between total testosterone and incident T2DM in a large population-based cohort.
Methods: Of 2117 men at baseline, 1589 were followed up 5 years later. Low total testosterone concentration at baseline determined by <10th percentile (10-year age-strata) were used as a risk factor for incident T2DM at follow-up. To evaluate for potential non-response bias, drop out weights were used in sensitivity analysis.
Results: From 1339 men eligible for analyses, 68 (5.1%) developed T2DM. Men with low total testosterone concentration had an increased risk of developing T2DM (odds ratio [OR] 3.4, 95% CI 1.9-6.1), even after adjustment for age, waist circumference and smoking, OR 3.0; (95% CI 1.6-5.7). Recalculated weighted models revealed almost identical estimates indicating no relevant non-response bias.
Discussion: Our prospective findings suggest that low total testosterone concentration is associated with incident T2DM in men and might represent a biomarker that might causally be involved in the risk of T2DM. This underlines the importance of measuring total testosterone in men as the predominant male sex hormone.
Similar articles
-
Inverse association between total testosterone concentrations, incident hypertension and blood pressure.Aging Male. 2011 Sep;14(3):176-82. doi: 10.3109/13685538.2010.529194. Epub 2010 Nov 19. Aging Male. 2011. PMID: 21087174
-
Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany.J Am Coll Cardiol. 2006 Oct 3;48(7):1369-77. doi: 10.1016/j.jacc.2006.06.053. Epub 2006 Sep 12. J Am Coll Cardiol. 2006. PMID: 17010797
-
Five-year changes in biologic risk factors and risk of type 2 diabetes: are attained but not initial risk factor levels of importance?Am J Epidemiol. 2012 Oct 15;176(8):720-5. doi: 10.1093/aje/kws189. Epub 2012 Sep 26. Am J Epidemiol. 2012. PMID: 23013621
-
Relative androgen deficiency in relation to obesity and metabolic status in older men.Diabetes Obes Metab. 2006 Jul;8(4):429-35. doi: 10.1111/j.1463-1326.2005.00532.x. Diabetes Obes Metab. 2006. PMID: 16776750
-
Living alone is associated with an increased risk of type 2 diabetes mellitus in men but not women from the general population: the MONICA/KORA Augsburg Cohort Study.Psychosom Med. 2009 Sep;71(7):784-8. doi: 10.1097/PSY.0b013e3181ae5770. Epub 2009 Jul 10. Psychosom Med. 2009. PMID: 19592514
Cited by
-
Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program.J Clin Endocrinol Metab. 2015 Oct;100(10):3778-86. doi: 10.1210/jc.2015-2328. Epub 2015 Jul 22. J Clin Endocrinol Metab. 2015. PMID: 26200237 Free PMC article. Clinical Trial.
-
Endogenous sex hormones, metabolic syndrome, and diabetes in men and women.Curr Cardiol Rep. 2014 Apr;16(4):467. doi: 10.1007/s11886-014-0467-6. Curr Cardiol Rep. 2014. PMID: 24585109 Free PMC article.
-
Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis.Endocr Connect. 2018 Jan;7(1):220-231. doi: 10.1530/EC-17-0253. Epub 2017 Dec 12. Endocr Connect. 2018. PMID: 29233816 Free PMC article.
-
Testosterone levels and risk of newly diagnosed type 2 diabetes mellitus in adult men: systematic review and meta-analysis.Endocrine. 2025 Feb;87(2):362-377. doi: 10.1007/s12020-024-04019-4. Epub 2024 Sep 9. Endocrine. 2025. PMID: 39251467
-
Burden of Male Hypogonadism and Major Comorbidities, and the Clinical, Economic, and Humanistic Benefits of Testosterone Therapy: A Narrative Review.Clinicoecon Outcomes Res. 2021 Jan 12;13:31-38. doi: 10.2147/CEOR.S285434. eCollection 2021. Clinicoecon Outcomes Res. 2021. PMID: 33488103 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical